Clinical Trial Update: Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 study evaluating 6(S)-5-MTHF (L-methylfolate) as an add-on in SSRI-resistant major depressive disorder; results from the trial were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• 6(S)-5-MTHF (L-methylfolate (5-MTHF))

Snippet

Sponsor: George I. Papakostas | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2013-01-18